Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NCATS's plan to grow the rare disease pipeline.

Nature reviews. Drug discovery·2023
Same author

GSK buys purine receptor antagonist for $2 billion.

Nature reviews. Drug discovery·2023
Same author

FDA approves second microbiome-based C. difficile therapy.

Nature reviews. Drug discovery·2023
Same author

Astellas buys complement inhibitor for $5.9 billion.

Nature reviews. Drug discovery·2023
Same author

Setting GPCRs free.

Nature reviews. Drug discovery·2023
Same author

Hotly anticipated ALS drug could pave way for more brain treatments.

Nature·2023

Related Experiment Video

Updated: May 13, 2026

Dual Raster-Scanning Photoacoustic Small-Animal Imager for Vascular Visualization
07:14

Dual Raster-Scanning Photoacoustic Small-Animal Imager for Vascular Visualization

Published on: July 15, 2020

Eli Lilly inks dual-payload ADCs deal

Asher Mullard

    Nature Reviews. Drug Discovery
    |May 11, 2026
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Highly-Multiplexed Tissue Imaging with Raman Dyes
    07:18

    Highly-Multiplexed Tissue Imaging with Raman Dyes

    Published on: April 21, 2022

    Related Experiment Videos

    Last Updated: May 13, 2026

    Dual Raster-Scanning Photoacoustic Small-Animal Imager for Vascular Visualization
    07:14

    Dual Raster-Scanning Photoacoustic Small-Animal Imager for Vascular Visualization

    Published on: July 15, 2020

    Highly-Multiplexed Tissue Imaging with Raman Dyes
    07:18

    Highly-Multiplexed Tissue Imaging with Raman Dyes

    Published on: April 21, 2022